FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to (2S)-2-amino-3-(3,4-bis((2-(benzoyloxy)-2-methylpropanoyl)oxy)phenyl)propanic acid, its salt, selected from acid-additive salts, salts of alkali metals, salts of alkali-earth metals, ammonium salts, tetramethylammonium salts, tetrabutylammonium salts, salts of pharmaceutically acceptable organic amines and salts of natural basic amino acids, or its, low-toxic an water-soluble solvate, which can be applied for prevention and/or treatment of Parkinson disease and/or Parkinson syndrome. Invention also relates to pharmaceutical composition and medication, containing (2S)-2-amino-3-(3,4-bis((2-(benzoyloxy)-2-methylpropanoyl)oxy)phenyl)propanic acid, its salt or solvate.
EFFECT: claimed (2S)-2-amino-3-(3,4-bis((2-(benzoyloxy)-2-methylpropanoyl)oxy)phenyl)propanic acid, its salt or solvate represents L-dopa prodrug, which makes it possible to provide effective concentration of L-dope in blood with small number of doses.
38 cl, 18 dwg, 7 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LEVODOP PRODRUGS, BASED ON THEM COMPOSITIONS AND THEIR APPLICATION | 2005 |
|
RU2365580C2 |
| METHOD OF PREPARING TAXAN AND TAXAN DERIVATIVES | 1991 |
|
RU2095356C1 |
| DERIVATIVES OF TAXANE | 1993 |
|
RU2188198C2 |
| NEW METHOD FOR INHIBITION OF VIRUS GROWTH AND/OR VIRULICIDE METHOD AND NOVEL ANALOG OF PYRAZINE NUCLEOTIDE OR PYRAZINE NUCLEOSIDE | 2002 |
|
RU2292894C2 |
| SUBSTITUTED PHENOXY-ACETIC ACIDS, WITH MODULATING EFFECT ON CRTh2 RECEPTORS | 2004 |
|
RU2372330C2 |
| DERIVATIVES OF 3-OXO-1-CYCLOBUTENE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2296753C2 |
| ARYLCYCLOALKYLAMINES DERIVATIVES NEUROPROTECTOR (VERSIONS), SUBSTANCES WITH COMBINED NEUROPROTECTOR, ANALGETIC AND ANTIDEPRESSIVE ACTION, PHARMACEUTICAL COMPOSITIONS BASED THEREON | 2016 |
|
RU2637928C2 |
| 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | 2013 |
|
RU2655170C2 |
| CARBOXYLIC ACID COMPOUND AND MEDICAL COMPOSITIONS CONTAINING THEREOF AS ACTIVE INGREDIENT | 2004 |
|
RU2375353C2 |
| PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
